MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Amphastar Pharmaceuticals Company Profile (NASDAQ:AMPH)

Consensus Ratings for Amphastar Pharmaceuticals (NASDAQ:AMPH) (?)
Ratings Breakdown: 3 Buy Rating(s), 1 Strong Buy Rating(s)
Consensus Rating:Buy (Score: 3.25)
Consensus Price Target: $21.25 (58.70% upside)

Analysts' Ratings History for Amphastar Pharmaceuticals (NASDAQ:AMPH)
Show:
DateFirmActionRatingPrice TargetActions
6/23/2015BMO Capital MarketsBoost Price Target$20.00 -> $22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/19/2015Needham & Company LLCBoost Price TargetBuy$17.00 -> $21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/3/2015Raymond JamesInitiated CoverageStrong-Buy$23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/15/2015BMO Capital MarketsReiterated RatingOutperform$19.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/14/2015Jefferies GroupSet Price TargetBuy$18.00 -> $19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/25/2015Jefferies GroupBoost Price TargetBuy$15.00 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/13/2014Jefferies GroupBoost Price TargetBuy$14.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/6/2014BMO Capital MarketsBoost Price Target$17.00 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/21/2014Needham & Company LLCInitiated CoverageBuy$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/21/2014Piper JaffrayInitiated CoverageOverweight$16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/21/2014BMO Capital MarketsInitiated CoverageOutperform$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/21/2014Jefferies GroupInitiated CoverageBuy$14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 8/31/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha